文献速递儿科与产科急症呼吸衰竭与机械通气重症综合管理与镇静镇痛

美国国家COVID队列协作组儿童SARS-CoV-2感染的特征、结局及严重度危险因素

Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative.
PubMed 文献 · JAMA Netw Open · 2022-02-01
一句话结论美国56个中心儿童SARS-CoV-2检测阳性率15.6%,住院儿童中13.9%为重症;入院当日生命体征和实验室指标可预测重症,MIS-C较急性COVID-19炎症反应和重症表型更重。

该前瞻性队列研究纳入美国56个N3C机构中19岁以下、2021年9月24日前有SARS-CoV-2检测结果的儿童,共1 068 410人接受检测,167 262例(15.6%)阳性。住院儿童10 245例(6.1%),其中1423例(13.9%)符合重症标准(机械通气、血管活性药物支持、ECMO或死亡)。男性、黑人/非裔美国人、肥胖及多种儿科复杂慢性病亚类与更高重症风险相关;入院当日生命体征和多项实验室指标可预测峰值疾病严重度。MIS-C患儿较急性COVID-19患儿有更明显的炎症实验室特征和更重的临床表型,有创通气率和血管活性药物支持需求更高。Delta期与pre-Delta期相比,住院率无显著变化,但重症 odds 降低。

要点

  • 住院儿童10 245例中1423例(13.9%)为重症:机械通气796例(7.8%)、血管活性药物支持868例(8.5%)、ECMO 42例(0.4%)、死亡131例(1.3%)。
  • 男性(OR 1.37;95%CI 1.21-1.56)、黑人/非裔美国人(OR 1.25;95%CI 1.06-1.47)、肥胖(OR 1.19;95%CI 1.01-1.41)及多种儿科复杂慢性病亚类与重症风险升高相关。
  • 入院当日生命体征和多项实验室指标可预测峰值疾病严重度,提示可用当日 readily available 数据早期识别可能进展为重症的儿童。
  • MIS-C较急性COVID-19:男性OR 1.59(95%CI 1.33-1.90)、黑人/非裔美国人OR 1.44(95%CI 1.17-1.77)、<12岁OR 1.81(95%CI 1.51-2.18)、肥胖OR 1.76(95%CI 1.40-2.22)、无儿科复杂慢性病OR 0.72(95%CI 0.65-0.80)。
  • MIS-C有创通气117/707(16.5%)vs 急性COVID-19 514/8241(6.2%)(P<.001);血管活性药物支持191/707(27.0%)vs 426/8241(5.2%)(P<.001)。

适用人群与场景

  • 美国56个N3C机构中19岁以下、初次SARS-CoV-2检测且就诊结束日期在2021年9月24日前的儿童。
  • 检测阳性儿童167 262例(15.6%),其中住院10 245例(6.1%)。

诊断标准与关键阈值

  • 重症疾病定义:符合机械通气、血管活性药物-正性肌力药物支持、ECMO或死亡之一。
  • MIS-C与急性COVID-19的鉴别基于临床诊断,原文未列出具体诊断标准。

研究设计与关键结果

  • 前瞻性队列研究,美国56个N3C机构,1 068 410名儿童接受SARS-CoV-2检测,167 262例(15.6%)阳性(82 882[49.6%]为女孩;中位年龄11.9[IQR 6.0-16.1]岁)。
  • 住院10 245例(6.1%),其中1423例(13.9%)为重症:机械通气796例(7.8%)、血管活性药物-正性肌力药物支持868例(8.5%)、ECMO 42例(0.4%)、死亡131例(1.3%)。
  • 重症风险因素:男性(OR 1.37;95%CI 1.21-1.56)、黑人/非裔美国人(OR 1.25;95%CI 1.06-1.47)、肥胖(OR 1.19;95%CI 1.01-1.41)及多种儿科复杂慢性病亚类。
  • 入院当日生命体征和多项实验室指标可预测峰值疾病严重度。
  • MIS-C vs 急性COVID-19的 odds 比:男性OR 1.59(95%CI 1.33-1.90)、黑人/非裔美国人OR 1.44(95%CI 1.17-1.77)、<12岁OR 1.81(95%CI 1.51-2.18)、肥胖OR 1.76(95%CI 1.40-2.22)、无儿科复杂慢性病OR 0.72(95%CI 0.65-0.80)。
  • MIS-C vs 急性COVID-19:有创通气117/707(16.5%)vs 514/8241(6.2%)(P<.001);血管活性药物-正性肌力药物支持191/707(27.0%)vs 426/8241(5.2%)(P<.001)。
  • Delta期 vs pre-Delta期:住院率1738(6.0%)vs 8507(6.2%)(P=.18),无显著变化;重症179(10.3%)vs 1242(14.6%),odds 降低至0.67倍(95%CI 0.57-0.79;P<.001)。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,利用入院当日 readily available 的数据元素(生命体征和实验室指标)可能实现早期识别可能进展为重症的儿童。
  • 作者指出,需要进一步工作将这些知识转化为结局改善。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Understanding of SARS-CoV-2 infection in US children has been limited by the lack of large, multicenter studies with granular data.

OBJECTIVE: To examine the characteristics, changes over time, outcomes, and severity risk factors of children with SARS-CoV-2 within the National COVID Cohort Collaborative (N3C).

DESIGN, SETTING, AND PARTICIPANTS: A prospective cohort study of encounters with end dates before September 24, 2021, was conducted at 56 N3C facilities throughout the US. Participants included children younger than 19 years at initial SARS-CoV-2 testing.

MAIN OUTCOMES AND MEASURES: Case incidence and severity over time, demographic and comorbidity severity risk factors, vital sign and laboratory trajectories, clinical outcomes, and acute COVID-19 vs multisystem inflammatory syndrome in children (MIS-C), and Delta vs pre-Delta variant differences for children with SARS-CoV-2.

RESULTS: A total of 1 068 410 children were tested for SARS-CoV-2 and 167 262 test results (15.6%) were positive (82 882 [49.6%] girls; median age, 11.9 [IQR, 6.0-16.1] years). Among the 10 245 children (6.1%) who were hospitalized, 1423 (13.9%) met the criteria for severe disease: mechanical ventilation (796 [7.8%]), vasopressor-inotropic support (868 [8.5%]), extracorporeal membrane oxygenation (42 [0.4%]), or death (131 [1.3%]). Male sex (odds ratio [OR], 1.37; 95% CI, 1.21-1.56), Black/African American race (OR, 1.25; 95% CI, 1.06-1.47), obesity (OR, 1.19; 95% CI, 1.01-1.41), and several pediatric complex chronic condition (PCCC) subcategories were associated with higher severity disease. Vital signs and many laboratory test values from the day of admission were predictive of peak disease severity. Variables associated with increased odds for MIS-C vs acute COVID-19 included male sex (OR, 1.59; 95% CI, 1.33-1.90), Black/African American race (OR, 1.44; 95% CI, 1.17-1.77), younger than 12 years (OR, 1.81; 95% CI, 1.51-2.18), obesity (OR, 1.76; 95% CI, 1.40-2.22), and not having a pediatric complex chronic condition (OR, 0.72; 95% CI, 0.65-0.80). The children with MIS-C had a more inflammatory laboratory profile and severe clinical phenotype, with higher rates of invasive ventilation (117 of 707 [16.5%] vs 514 of 8241 [6.2%]; P < .001) and need for vasoactive-inotropic support (191 of 707 [27.0%] vs 426 of 8241 [5.2%]; P < .001) compared with those who had acute COVID-19. Comparing children during the Delta vs pre-Delta eras, there was no significant change in hospitalization rate (1738 [6.0%] vs 8507 [6.2%]; P = .18) and lower odds for severe disease (179 [10.3%] vs 1242 [14.6%]) (decreased by a factor of 0.67; 95% CI, 0.57-0.79; P < .001).

CONCLUSIONS AND RELEVANCE: In this cohort study of US children with SARS-CoV-2, there were observed differences in demographic characteristics, preexisting comorbidities, and initial vital sign and laboratory values between severity subgroups. Taken together, these results suggest that early identification of children likely to progress to severe disease could be achieved using readily available data elements from the day of admission. Further work is needed to translate this knowledge into improved outcomes.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Martin B, DeWitt PE, Russell S, et al. Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative. JAMA Netw Open. 2022. PMID: 35133437. doi:10.1001/jamanetworkopen.2021.43151

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。